(Q40079604)

17 September 2017

title

Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial (English)

1 reference

familial Mediterranean fever

17 September 2017

0 references

1 reference

1 reference

1 reference

6

Shaye Kivity

1 reference

17 September 2017

1

Ilan Ben-Zvi

1 reference

17 September 2017

Olga Kukuy

2

1 reference

17 September 2017

Eitan Giat

3

1 reference

17 September 2017

Elon Pras

4

1 reference

17 September 2017

Olga Feld

5

1 reference

17 September 2017

Oleg Perski

7

1 reference

17 September 2017

Gil Bornstein

8

1 reference

17 September 2017

Chagai Grossman

9

1 reference

17 September 2017

Gil Harari

10

1 reference

17 September 2017

Merav Lidar

11

1 reference

17 September 2017

Avi Livneh

12

1 reference

17 September 2017

publication date

11 November 2016

1 reference

17 September 2017

published in

Arthritis & Rheumatology

1 reference

17 September 2017

volume

69

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

854-862

1 reference

Familial mediterranean Fever in the world

17 September 2017

cites work

1 reference

Familial Mediterranean fever. A survey of 470 cases and review of the literature

21 January 2018

1 reference

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production

21 January 2018

1 reference

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy

21 January 2018

1 reference

Colchicine--Update on mechanisms of action and therapeutic uses

21 January 2018

1 reference

Diagnostic and treatment concerns in familial Mediterranean fever

21 January 2018

1 reference

Evidence-based recommendations for the practical management of Familial Mediterranean Fever

21 January 2018

1 reference

Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization

21 January 2018

1 reference

EULAR recommendations for the management of familial Mediterranean fever

21 January 2018

1 reference

Chronic inflammation in FMF: markers, risk factors, outcomes and therapy

21 January 2018

1 reference

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

21 January 2018

1 reference

IL-1 blockade in autoinflammatory syndromes

21 January 2018

1 reference

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

21 January 2018

1 reference

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study

21 January 2018

1 reference

Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra

21 January 2018

1 reference

Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine

21 January 2018

1 reference

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

21 January 2018

1 reference

Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine

21 January 2018

1 reference

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature

21 January 2018

1 reference

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

21 January 2018

1 reference

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

21 January 2018

1 reference

Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents

21 January 2018

1 reference

Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients

21 January 2018

1 reference

Efficacy of interleukin-1 targeting treatments in patients with familial mediterranean Fever.

21 January 2018

1 reference

Criteria for the diagnosis of familial Mediterranean fever

21 January 2018

1 reference

FMF50: a score for assessing outcome in familial Mediterranean fever.

21 January 2018

1 reference

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

21 January 2018

1 reference

Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis

21 January 2018

1 reference

Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.

21 January 2018

1 reference

Long-term colchicine treatment in children with familial mediterranean fever

21 January 2018

1 reference

Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever

21 January 2018

1 reference

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

Incomplete response to colchicine in M694V homozygote FMF patients

21 January 2018

1 reference

21 January 2018

1 reference

Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients

21 January 2018

1 reference

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

21 January 2018

1 reference

Treating inflammation by blocking interleukin-1 in humans

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.39995

1 reference

17 September 2017

1 reference